News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Danny Burke: Series of interviews from the World Cancer Congress
Danny Burke/LinkedIn
Oct 27, 2024, 13:50

Danny Burke: Series of interviews from the World Cancer Congress

Danny Burke, CEO at Ecancer, shared a post on LinkedIn:

“Our series of interviews from the World Cancer Congress are now live. They feature leading global cancer experts discussing a range of topics.

Access these videos for free as part of our comprehensive collection of open-access cancer videos.”

Watch here.

cancer Danny Burke ecancer global cancer experts OncoDaily Oncology World  Cancer Congress
Special Coverage
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene
Blog
Mar 31, 2025, 18:21
Cecilia Pompili: PROs research from ELCC25 on NSCLC treatment and thoracic surgery
Blog
Mar 31, 2025, 18:15
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Blog
Mar 31, 2025, 18:09
Ray Chan: Can’t wait for William Dale’s lecture this Thursday at Flinders University
Science
Mar 31, 2025, 18:00
Partha Basu: Guidance from IARC/WHO on validating HPV detection tests with lower valency